ATE469155T1 - Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer - Google Patents
Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmerInfo
- Publication number
- ATE469155T1 ATE469155T1 AT07811934T AT07811934T ATE469155T1 AT E469155 T1 ATE469155 T1 AT E469155T1 AT 07811934 T AT07811934 T AT 07811934T AT 07811934 T AT07811934 T AT 07811934T AT E469155 T1 ATE469155 T1 AT E469155T1
- Authority
- AT
- Austria
- Prior art keywords
- indolebenzazepine
- fusioned
- cyclopropyl
- hcv ns5b
- ns5b inhibitors
- Prior art date
Links
- 108700008776 hepatitis C virus NS-5 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyurethanes Or Polyureas (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80833106P | 2006-05-25 | 2006-05-25 | |
PCT/US2007/069660 WO2007140254A2 (en) | 2006-05-25 | 2007-05-24 | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE469155T1 true ATE469155T1 (de) | 2010-06-15 |
Family
ID=38617899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07811934T ATE469155T1 (de) | 2006-05-25 | 2007-05-24 | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer |
Country Status (9)
Country | Link |
---|---|
US (1) | US7456167B2 (de) |
EP (1) | EP2029606B1 (de) |
JP (1) | JP5205370B2 (de) |
CN (1) | CN101490054B (de) |
AT (1) | ATE469155T1 (de) |
DE (1) | DE602007006796D1 (de) |
ES (1) | ES2343914T3 (de) |
NO (1) | NO20084645L (de) |
WO (1) | WO2007140254A2 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1688420A4 (de) * | 2003-11-19 | 2008-10-22 | Japan Tobacco Inc | 5-5-gliedrige kondensierte heterocyclische verbindung und deren verwendung als hcv-polymeraseinhibitor |
US20070049593A1 (en) * | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
US7521443B2 (en) * | 2006-05-17 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7541351B2 (en) * | 2007-01-11 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7541352B2 (en) * | 2007-02-02 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7517872B2 (en) * | 2007-02-22 | 2009-04-14 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7998951B2 (en) * | 2007-03-05 | 2011-08-16 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
US7538102B2 (en) * | 2007-03-14 | 2009-05-26 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US7521444B2 (en) * | 2007-03-14 | 2009-04-21 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7541353B2 (en) * | 2007-03-14 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7547690B2 (en) * | 2007-03-14 | 2009-06-16 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US7538103B2 (en) * | 2007-03-15 | 2009-05-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
ATE548044T1 (de) | 2007-05-04 | 2012-03-15 | Vertex Pharma | Kombinationstherapie zur behandlung von hiv- infektionen |
US7652004B2 (en) * | 2007-08-09 | 2010-01-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8143243B2 (en) * | 2007-08-09 | 2012-03-27 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7642251B2 (en) * | 2007-08-09 | 2010-01-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
SI2209789T1 (sl) * | 2007-11-20 | 2012-06-29 | Bristol Myers Squibb Co | Ciklopropil zliti indolobenzazepin hcv ns5b inhibitorji |
US8129367B2 (en) * | 2007-11-21 | 2012-03-06 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US8124601B2 (en) | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US8476257B2 (en) | 2007-12-19 | 2013-07-02 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
WO2009120745A1 (en) * | 2008-03-27 | 2009-10-01 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis c |
JP2011515496A (ja) * | 2008-03-27 | 2011-05-19 | ブリストル−マイヤーズ スクイブ カンパニー | ジオキソランおよびジオキソラノン縮合インドロベンザジアゼピンhcvns5b阻害剤 |
US8431568B2 (en) | 2008-03-27 | 2013-04-30 | Bristol-Myers Squibb Company | Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors |
EP2280978B1 (de) * | 2008-03-27 | 2013-04-24 | Bristol-Myers Squibb Company | Pyrrolidinkondensierte indolobenzadiazepine als hcv-ns5b-inhibitoren |
US8133884B2 (en) * | 2008-05-06 | 2012-03-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
MX2011006891A (es) | 2008-12-23 | 2011-10-06 | Pharmasset Inc | Fosforamidatos de nucleosidos. |
NZ593647A (en) | 2008-12-23 | 2013-08-30 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
EP2376514A2 (de) | 2008-12-23 | 2011-10-19 | Pharmasset, Inc. | Nukleosidanaloga |
SG172848A1 (en) | 2009-01-07 | 2011-08-29 | Scynexis Inc | Cyclosporine derivative for use in the treatment of hcv and hiv infection |
US8143244B2 (en) * | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
JP5872539B2 (ja) | 2010-03-31 | 2016-03-01 | ギリアド ファーマセット エルエルシー | プリンヌクレオシドホスホルアミダート |
US8563530B2 (en) | 2010-03-31 | 2013-10-22 | Gilead Pharmassel LLC | Purine nucleoside phosphoramidate |
AU2011235112B2 (en) | 2010-03-31 | 2015-07-09 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
AU2011336632B2 (en) | 2010-11-30 | 2015-09-03 | Gilead Pharmasset Llc | Compounds |
CA2822357A1 (en) | 2010-12-22 | 2012-06-28 | Abbvie Inc. | Hepatitis c inhibitors and uses thereof |
NZ623396A (en) | 2011-09-16 | 2016-07-29 | Gilead Pharmasset Llc | Methods for treating hcv |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
LT2950786T (lt) | 2013-01-31 | 2020-03-10 | Gilead Pharmasset Llc | Dviejų antivirusinių junginių preparatų kompozicija |
NZ716840A (en) | 2013-08-27 | 2017-06-30 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE428714T1 (de) * | 2004-02-24 | 2009-05-15 | Japan Tobacco Inc | Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor |
US7348425B2 (en) | 2004-08-09 | 2008-03-25 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
DE502005002697D1 (de) | 2004-10-13 | 2008-03-13 | Merck Patent Gmbh | Als kinaseinhibitoren geeignete derivate des n,n'-diphenylharnstoffs |
EP1807397A2 (de) * | 2004-10-26 | 2007-07-18 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Tetrazyklische indolderivate als antivirale wirkstoffe |
GB0518390D0 (en) | 2005-09-09 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7473688B2 (en) | 2005-09-13 | 2009-01-06 | Bristol-Myers Squibb Company | Indolobenzazepine HCV NS5B inhibitors |
US7456165B2 (en) | 2006-02-08 | 2008-11-25 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
US7456166B2 (en) * | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
-
2007
- 2007-05-24 US US11/753,137 patent/US7456167B2/en active Active
- 2007-05-24 CN CN200780027545XA patent/CN101490054B/zh not_active Expired - Fee Related
- 2007-05-24 EP EP07811934A patent/EP2029606B1/de active Active
- 2007-05-24 WO PCT/US2007/069660 patent/WO2007140254A2/en active Application Filing
- 2007-05-24 DE DE602007006796T patent/DE602007006796D1/de active Active
- 2007-05-24 ES ES07811934T patent/ES2343914T3/es active Active
- 2007-05-24 AT AT07811934T patent/ATE469155T1/de not_active IP Right Cessation
- 2007-05-24 JP JP2009512305A patent/JP5205370B2/ja not_active Expired - Fee Related
-
2008
- 2008-11-04 NO NO20084645A patent/NO20084645L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20084645L (no) | 2008-12-19 |
EP2029606B1 (de) | 2010-05-26 |
WO2007140254A2 (en) | 2007-12-06 |
CN101490054B (zh) | 2012-05-16 |
CN101490054A (zh) | 2009-07-22 |
DE602007006796D1 (de) | 2010-07-08 |
ES2343914T3 (es) | 2010-08-12 |
US7456167B2 (en) | 2008-11-25 |
JP2009538347A (ja) | 2009-11-05 |
EP2029606A2 (de) | 2009-03-04 |
JP5205370B2 (ja) | 2013-06-05 |
US20070275947A1 (en) | 2007-11-29 |
WO2007140254A3 (en) | 2008-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE469155T1 (de) | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer | |
DK1987038T3 (da) | HCV NS5B-hæmmere | |
DK2209789T3 (da) | Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere | |
TW200745120A (en) | Indolobenzazepine HCV NS5B inhibitors | |
EA200802346A1 (ru) | Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с | |
WO2007140200A3 (en) | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors | |
ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
NO20091871L (no) | Hepatitt C virus inhibitorer | |
ATE494291T1 (de) | Verbindungen zur behandlung von hepatitis c | |
CY1113752T1 (el) | Μακροκυκλικες ενωσεις κινοξαλινης ως αναστολεις πρωτεασεις ns3 του hcv | |
EA200900676A1 (ru) | Ингибиторы вируса гепатита с | |
MX2009004556A (es) | Inhibidores de la proteasa ns3 del hcv. | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
NO20091845L (no) | Macrocykliske peptider som hepatitt C virus-inhibitorer | |
EA200901101A1 (ru) | Макроциклические соединения в качестве ингибиторов протеазы ns3 вгс | |
NO20091846L (no) | Makrocykliske peptider som hepatitt C virus- inhibitorer | |
MX2010001416A (es) | Compuesto para el tratamiento de la hepatitis c. | |
ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
EA201000948A1 (ru) | Ингибиторы вирусной полимеразы | |
ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
MX2010010235A (es) | Inhibidores de ns5b de virus de la hepatitis c de indolobenzadiazepina fusionados a pirrolidina. | |
UA95990C2 (en) | Hcv ns3 protease inhibitors | |
ATE531373T1 (de) | Aromatische heterocyclische kondensierte indolobenzadiazepin-hcv-ns5b-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |